| Attributes | Values |
|---|
| rdf:type
| |
| description
| - article científic (ca)
- article scientific (oc)
- articol științific (ro)
- articolo scientifico (it)
- artigo científico (gl)
- artikull shkencor (sq)
- artikulong pang-agham (tl)
- artykuł naukowy (pl)
- bilimsel makale (tr)
- mokslinis straipsnis (lt)
- scienca artikolo (eo)
- teaduslik artikkel (et)
- tieteellinen artikkeli (fi)
- tudományos cikk (hu)
- vedecký článok (sk)
- vetenskaplig artikel (sv)
- vitenskapelig artikkel (nb)
- vitskapeleg artikkel (nn)
- vědecký článek (cs)
- wetenschappelijk artikel (nl)
- wissenschaftlicher Artikel (de)
- επιστημονικό άρθρο (el)
- мақолаи илмӣ (tg)
- научна статия (bg)
- научная статья (ru)
- научни чланак (sr)
- מאמר מדעי (he)
- სამეცნიერო სტატია (ka)
- บทความทางวิทยาศาสตร์ (th)
- artikel ilmiah (id)
- bài báo khoa học (vi)
- naučni članak (sr-el)
- мақолаи илмӣ (tg-cyrl)
- научни чланак (sr-ec)
- գիտական հոդված (hy)
- سائنسی مضمون (ur)
- مقالهٔ علمی (fa)
- ২০১৪-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ (bn)
- 2014 nî lūn-bûn (nan)
- 2014年の論文 (ja)
- 2014年学术文章 (zh-cn)
- 2014年学术文章 (zh-sg)
- 2014年学术文章 (zh-hans)
- 2014年学术文章 (wuu)
- 2014年学术文章 (zh-my)
- 2014年學術文章 (zh)
- 2014年學術文章 (zh-hk)
- 2014年學術文章 (zh-tw)
- 2014年學術文章 (zh-hant)
- 2014年學術文章 (yue)
- 2014年學術文章 (zh-mo)
- 2014년 논문 (ko)
- artigo científico (publicado na 2014) (pt)
- artigo científico (publicado na 2014) (pt-br)
- artículo científico publicado en 2014 (es)
- artículu científicu espublizáu en 2014 (ast)
- videnskabelig artikel (udgivet 2014) (da)
- наукова стаття, опублікована в січні 2014 (uk)
- article scientifique publié en 2014 (fr)
- scientific article published on 06 January 2014 (en)
- مقالة علمية نشرت في 06 يناير 2014 (ar)
- scientific article published on 06 January 2014 (en-ca)
- scientific article published on 06 January 2014 (en-gb)
|
| publication date
| |
| publication date
| |
| language of work or name
| |
| language of work or name
| |
| cites work
| |
| cites work
| - The clinical significance of drug-drug interactions in the era of direct-acting anti-viral agents against chronic hepatitis C.
- Sofosbuvir for hepatitis C genotype 2 or 3 in patients without treatment options
- Sofosbuvir for previously untreated chronic hepatitis C infection
- Nucleotide polymerase inhibitor sofosbuvir plus ribavirin for hepatitis C.
- Sofosbuvir, a nucleotide polymerase inhibitor, for the treatment of chronic hepatitis C virus infection
- Sofosbuvir with pegylated interferon alfa-2a and ribavirin for treatment-naive patients with hepatitis C genotype-1 infection (ATOMIC): an open-label, randomised, multicentre phase 2 trial
- Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial
- A novel promising therapeutic option against hepatitis C virus: an oral nucleotide NS5B polymerase inhibitor sofosbuvir
- Genotype and subtype profiling of PSI-7977 as a nucleotide inhibitor of hepatitis C virus
- Sofosbuvir (GS-7977) plus peginterferon/ribavirin in treatment-naïve patients with HCV genotype 1: a randomized, 28-day, dose-ranging trial
- Comparative effectiveness of the hepatitis C virus protease inhibitors boceprevir and telaprevir in a large U.S. cohort
- HCV genotype 1a shows a better virological response to antiviral therapy than HCV genotype 1b.
|
| author name string
| |
| author name string
| |
| rdfs:label
| - Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection (en)
- Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection (nl)
- Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection (ast)
|
| skos:prefLabel
| - Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection (en)
- Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection (nl)
- Review article: the efficacy and safety of sofosbuvir, a novel, oral nucleotide NS5B polymerase inhibitor, in the treatment of chronic hepatitis C virus infection (ast)
|
![[RDF Data]](/fct/images/sw-rdf-blue.png)
![[cxml]](/fct/images/cxml_doc.png)
![[csv]](/fct/images/csv_doc.png)
![[text]](/fct/images/ntriples_doc.png)
![[turtle]](/fct/images/n3turtle_doc.png)
![[ld+json]](/fct/images/jsonld_doc.png)
![[rdf+json]](/fct/images/json_doc.png)
![[rdf+xml]](/fct/images/xml_doc.png)
![[atom+xml]](/fct/images/atom_doc.png)
![[html]](/fct/images/html_doc.png)